MEDIFAST INC (MED) › Cash & EquivalentsMEDIFAST INC (MED) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $973.0K2009: $10.60M2010: $17.16M2011: $14.26M2012: $39.94M2013: $36.38M2014: $24.46M2015: $42.04M2016: $52.44M2017: $75.08M2018: $81.36M2019: $76.97M2020: $163.72M2021: $104.18M2022: $87.69M2023: $94.44M2024: $90.93M2025: $89.30M$89.30M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$89.30M-1.8%2024$90.93M-3.7%2023$94.44M+7.7%2022$87.69M-15.8%2021$104.18M-36.4%2020$163.72M+112.7%2019$76.97M-5.4%2018$81.36M+8.4%2017$75.08M+43.2%2016$52.44M+24.7%2015$42.04M+71.9%2014$24.46M-32.8%2013$36.38M-8.9%2012$39.94M+180.0%2011$14.26M-16.9%2010$17.16M+61.9%2009$10.60M+989.8%2008$973.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share